144 related articles for article (PubMed ID: 27306335)
1. β-Catenin modulation in neurofibromatosis type 1 bone repair: therapeutic implications.
Ghadakzadeh S; Kannu P; Whetstone H; Howard A; Alman BA
FASEB J; 2016 Sep; 30(9):3227-37. PubMed ID: 27306335
[TBL] [Abstract][Full Text] [Related]
2. A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells.
El-Hoss J; Sullivan K; Cheng T; Yu NY; Bobyn JD; Peacock L; Mikulec K; Baldock P; Alexander IE; Schindeler A; Little DG
J Bone Miner Res; 2012 Jan; 27(1):68-78. PubMed ID: 21956219
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologically targeting beta-catenin for NF1 associated deficiencies in fracture repair.
Baht GS; Nadesan P; Silkstone D; Alman BA
Bone; 2017 May; 98():31-36. PubMed ID: 28254468
[TBL] [Abstract][Full Text] [Related]
4. Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing.
Chen Y; Whetstone HC; Lin AC; Nadesan P; Wei Q; Poon R; Alman BA
PLoS Med; 2007 Jul; 4(7):e249. PubMed ID: 17676991
[TBL] [Abstract][Full Text] [Related]
5. Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.
Sharma R; Wu X; Rhodes SD; Chen S; He Y; Yuan J; Li J; Yang X; Li X; Jiang L; Kim ET; Stevenson DA; Viskochil D; Xu M; Yang FC
Hum Mol Genet; 2013 Dec; 22(23):4818-28. PubMed ID: 23863460
[TBL] [Abstract][Full Text] [Related]
6. Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling.
Jin H; Wang B; Li J; Xie W; Mao Q; Li S; Dong F; Sun Y; Ke HZ; Babij P; Tong P; Chen D
Bone; 2015 Feb; 71():63-75. PubMed ID: 25263522
[TBL] [Abstract][Full Text] [Related]
7. Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.
Rhodes SD; Wu X; He Y; Chen S; Yang H; Staser KW; Wang J; Zhang P; Jiang C; Yokota H; Dong R; Peng X; Yang X; Murthy S; Azhar M; Mohammad KS; Xu M; Guise TA; Yang FC
J Bone Miner Res; 2013 Dec; 28(12):2476-89. PubMed ID: 23703870
[TBL] [Abstract][Full Text] [Related]
8. Disturbed osteoblastic differentiation of fibrous hamartoma cell from congenital pseudarthrosis of the tibia associated with neurofibromatosis type I.
Lee DY; Cho TJ; Lee HR; Lee K; Moon HJ; Park MS; Yoo WJ; Chung CY; Choi IH
Clin Orthop Surg; 2011 Sep; 3(3):230-7. PubMed ID: 21909471
[TBL] [Abstract][Full Text] [Related]
9. Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.
de la Croix Ndong J; Stevens DM; Vignaux G; Uppuganti S; Perrien DS; Yang X; Nyman JS; Harth E; Elefteriou F
J Bone Miner Res; 2015 Jan; 30(1):55-63. PubMed ID: 25043591
[TBL] [Abstract][Full Text] [Related]
10. Models of tibial fracture healing in normal and Nf1-deficient mice.
Schindeler A; Morse A; Harry L; Godfrey C; Mikulec K; McDonald M; Gasser JA; Little DG
J Orthop Res; 2008 Aug; 26(8):1053-60. PubMed ID: 18383150
[TBL] [Abstract][Full Text] [Related]
11. A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I Pseudarthrosis.
El-Hoss J; Cheng T; Carpenter EC; Sullivan K; Deo N; Mikulec K; Little DG; Schindeler A
J Bone Joint Surg Am; 2014 Jul; 96(14):e117. PubMed ID: 25031379
[TBL] [Abstract][Full Text] [Related]
12. Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression.
Leskelä HV; Kuorilehto T; Risteli J; Koivunen J; Nissinen M; Peltonen S; Kinnunen P; Messiaen L; Lehenkari P; Peltonen J
Bone; 2009 Feb; 44(2):243-50. PubMed ID: 19061981
[TBL] [Abstract][Full Text] [Related]
13. NF1 gene expression in mouse fracture healing and in experimental rat pseudarthrosis.
Kuorilehto T; Ekholm E; Nissinen M; Hietaniemi K; Hiltunen A; Paavolainen P; Penttinen R; Peltonen J
J Histochem Cytochem; 2006 Mar; 54(3):363-70. PubMed ID: 16314442
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice.
Loiselle AE; Lloyd SA; Paul EM; Lewis GS; Donahue HJ
PLoS One; 2013; 8(11):e81399. PubMed ID: 24260576
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.
Paria N; Cho TJ; Choi IH; Kamiya N; Kayembe K; Mao R; Margraf RL; Obermosser G; Oxendine I; Sant DW; Song MH; Stevenson DA; Viskochil DH; Wise CA; Kim HK; Rios JJ
J Bone Miner Res; 2014 Dec; 29(12):2636-42. PubMed ID: 24932921
[TBL] [Abstract][Full Text] [Related]
16. Improved union and bone strength in a mouse model of NF1 pseudarthrosis treated with recombinant human bone morphogenetic protein-2 and zoledronic acid.
Deo N; Cheng TL; Mikulec K; Peacock L; Little DG; Schindeler A
J Orthop Res; 2018 Mar; 36(3):930-936. PubMed ID: 28767180
[TBL] [Abstract][Full Text] [Related]
17. Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate.
Schindeler A; Birke O; Yu NY; Morse A; Ruys A; Baldock PA; Little DG
J Bone Joint Surg Br; 2011 Aug; 93(8):1134-9. PubMed ID: 21768643
[TBL] [Abstract][Full Text] [Related]
18. Beta-catenin in the race to fracture repair: in it to Wnt.
Silkstone D; Hong H; Alman BA
Nat Clin Pract Rheumatol; 2008 Aug; 4(8):413-9. PubMed ID: 18560386
[TBL] [Abstract][Full Text] [Related]
19. Molecular Dissection of Somatic Skeletal Disease in Neurofibromatosis Type 1.
Paria N; Khalid A; Shen B; Lemoine B; Chan J; Kidane YH; Oxendine I; Cornelia R; Wise CA; Rios JJ
J Bone Miner Res; 2023 Feb; 38(2):288-299. PubMed ID: 36459048
[TBL] [Abstract][Full Text] [Related]
20. Biologic characteristics of fibrous hamartoma from congenital pseudarthrosis of the tibia associated with neurofibromatosis type 1.
Cho TJ; Seo JB; Lee HR; Yoo WJ; Chung CY; Choi IH
J Bone Joint Surg Am; 2008 Dec; 90(12):2735-44. PubMed ID: 19047720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
